Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease

Burbulla, Lena F., Song, Pingping, Mazzulli, Joseph R., Zampese, Enrico, Wong, Yvette C., Jeon, Sohee, Santos, David P., Blanz, Judith +8 more·2017·Science

DOI 10.1126/science.aam9080

Cited by (875)

Items 801–875 of 875

A Load-Induced Energetic Tipping Point Explains Selective Vulnerability of Substantia Nigra Neurons
Max Anfilofyev · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Neuromelanin: Bridging catecholamine metabolism and neurodegeneration in Parkinson's disease
Marta González-Sepúlveda, Joana M. Cladera-Sastre, Miquel Vila · 2025 · Handbook of behavioral neuroscience
The role of mitochondria in the pathogenesis of Parkinson's disease
Sofia Koletsi, Giuseppe Uras, Anthony H.V. Schapira · 2025 · Handbook of behavioral neuroscience
Micronuclear collapse under oxidative stress drives amphisome-mediated export of DNA in Parkinson’s disease
H Tavares, O Gonçalves, Rita Gaspar, Margarida Beatriz, Cláudia M. Deus, Sofia Benfeito, Fernando Cagide, Fernanda Borges, Philip Seibler, Christine Klein et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Amyloid‐Inducing Agents via Metabolite Self‐Assembly Expands the Boundary of Prion Concept beyond Proteins
Kailash Prasad Prajapati, Shikha Mittal, Masihuzzaman Ansari, Bibin Gnanadhason Anand, Karunakar Kar · 2025 · ChemBioChem
Additional file 3 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Rupsha Mondal, Chayan Banerjee, Sumangal Nandy, Moumita Roy, Joy Chakraborty · 2023 · Figshare
Additional file 2 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Rupsha Mondal, Chayan Banerjee, Sumangal Nandy, Moumita Roy, Joy Chakraborty · 2023 · Figshare
Additional file 8 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Rupsha Mondal, Chayan Banerjee, Sumangal Nandy, Moumita Roy, Joy Chakraborty · 2023 · Figshare
Additional file 6 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Rupsha Mondal, Chayan Banerjee, Sumangal Nandy, Moumita Roy, Joy Chakraborty · 2023 · Figshare
Additional file 1 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Rupsha Mondal, Chayan Banerjee, Sumangal Nandy, Moumita Roy, Joy Chakraborty · 2023 · Figshare
Additional file 1 of Parkin coregulates glutathione metabolism in adult mammalian brain
El Kodsi, Daniel N., Jacqueline M. Tokarew, Rajib Sengupta, Nathalie A. Lengacher, Ajanta Chatterji, Angela Nguyen, Heather Boston, Qiubo Jiang, Carina Palmberg, Chantal A. Pileggi et al. · 2024 · Figshare
Additional file 5 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Rupsha Mondal, Chayan Banerjee, Sumangal Nandy, Moumita Roy, Joy Chakraborty · 2023 · Figshare
Additional file 1 of Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson’s disease
Chen, Bing, Zhang, Qian, Xiaoru Zhong, Zhang, Xinwei, Liu, Xin, Wang, Hongyang, Yang, Fan, Zhang, Jingjing, Jingnan Huang, Wong, Yin-Kwan et al. · 2024 · Figshare
Additional file 7 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Rupsha Mondal, Chayan Banerjee, Sumangal Nandy, Moumita Roy, Joy Chakraborty · 2023 · Figshare
Additional file 4 of Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Rupsha Mondal, Chayan Banerjee, Sumangal Nandy, Moumita Roy, Joy Chakraborty · 2023 · Figshare
Zn( ii )-based tyramine-conjugated porphyrin complex as an active tyrosinase inhibitor for potential neuroprotection by improving the mitochondrial homeostasis
Kai Lyu, Qiu-Yun Chen, Jing-Jing Liu, Hongqun Ding, Feng Chen, Gaoji Wang · 2026 · New Journal of Chemistry
The Vesicular Glutamate Transporter Modulates Sex and Region-Specific Differences in Dopaminergic Neuron α-Synuclein Toxicity by Modifying Cytosolic Dopamine Levels
Kevin Garzillo, Mia Perulli, Daniel T. Babcock · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Dopamine release from Parkinson’s patient-derived neurons is disrupted due to impaired synaptic vesicle loading
Kaitlyn M. L. Cramb, Humaira Noor, Iona Thomas-Wright, Maria Claudia Caiazza, Sándor Szunyogh, Ira Milošević, Dayne A. Beccano-Kelly, Stephanie Jane Cragg, Richard Wade‐Martins · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
A Wireless Endovascular Deep Brain Stimulator for Parkinson's Disease
Jinliang Ren, Jiaxin Huang, Zhuoling Cheng, Hui Xu, Jingtao Yang, Xinyue Zhang, Mingyu Sun, Keni Shi, Xiaona Cao, Huawei Jin et al. · 2026 · Advanced Materials Technologies
Suppression of pre-B cell colony formation by catecholamine oxidation
Nathan T. Roberts, Saeed Daneshmandi, Jee Eun Choi, Elizabeth A. Repasky · 2026 · The Journal of Immunology
Single-cell resolution uncovers cell type-specific dysregulation in Parkin-deficient neuron-microglia co-cultures
Evelyn Knappe, Kristian Händler, Linn Streubel-Gallasch, Franziska Rudolph, Daniel Alvarez‐Fischer, Sally A. Cowley, Anne Grünewald, Malte Spielmann, Christine Klein, Philip Seibler · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
High dopamine impairs early neuronal identity and morphology in human hippocampal progenitor cells
Miryam Ravji, Gargi Mandal, Lucia Batzu, Sandrine Thuret · 2026 · Frontiers in Cell and Developmental Biology
Les faces cachées de l’apomorphine : leçons passées, contributions expérimentales actuelles et défis futurs
Manon Auffret · 2017
Study of neuronal networks and mechanisms implicated in locomotor reactivity and Parkinson's disease pathogenesis in the Drosophila model
Jun Sun · 2018 · theses.fr (ABES)
Impact de la déficience de la protéine de réponse au stress TP53INP1 sur la dégénérescence des neurones dopaminergiques nigraux au cours du vieillissement normal et en condition parkinsonienne
Emilie Hoang Dinh · 2020
Research Progress on the Mechanisms of Polyunsaturated Fatty Acids in Parkinson’s Disease
丽杨 · 2026 · Advances in Clinical Medicine
Characterising the role of alpha synuclein in Ferroptosis, in the context of Parkinson's Disease
Laura Mahoney‐Sanchez · 2022
Simulations de dynamique moléculaire à haute résolution des isoformes 1 et 2 de la pyruvate kinase musculaire
Quentin Delobelle · 2024 · theses.fr (ABES)
Rôle du métabolisme des acides gras polyinsaturés et du fer dans la vulnérabilité des neurones dopaminergiques à la ferroptose : nouvelles approches pharmacologiques pour la maladie de Parkinson.
Hind Bouchaoui · 2024
Nitrogen- and selenium-containing heterocycles, synthesis, reactivity and application as glutathione peroxidases mimics
Alexandre Karnat · 2024
Impacts de la modulation du cholestérol cérébral dans la maladie de Parkinson
Lisa Rousselot · 2023 · theses.fr (ABES)
When R‐Loops Go Awry: Genome Instability and Neurological Diseases
Nur Rasyiqin Rasli, Yu Katsuyama · 2026 · European Journal of Neuroscience
Zebrafish Models of Parkinson’s Disease: From Pathogenesis to Drug Discovery
Hae‐Chul Park, Yongbo Seo, Yeo Jeong Han, Su Hee Cho, Myung Ji Kim · 2026 · International Journal of Molecular Sciences
Upregulated PKM2 Protects Dopaminergic Neurons From Oxidative Damage Through Nrf2 Transactivation in an MPTP ‐Induced Mouse Model of Parkinson's Disease
Meng Mei, QianQian Miao, M T Li, Hao‐ran Wang, Jian‐hua Ding, Gang Hu, Yao Wei · 2026 · CNS Neuroscience & Therapeutics
The shift from 2D to 3D cell culture in neurobiology: implications for precision medicine and organ-on-chip technologies
Farnam Gholipour Maralan · 2026 · Beni-Suef University Journal of Basic and Applied Sciences
Selective vulnerability of dopaminergic neurons in Parkinson’s disease connects PRKN and differential expression of CHCHD2 and GPNMB
Franca Vulinović, Arian Hach, Zied Landoulsi, Kerstin Tanzer, Daniel Alvarez‐Fischer, Philip Seibler, Christine Klein, Patrick May, Aleksandar Raković · 2026 · Cell Death and Disease
Alpha-synuclein at the crossroads of host–virus interactions: immunological roles beyond the nervous system
Valentina Artusa, Fiona Limanaqi, Elena Santacroce, Mario Clerici, Andrea Cossarizza, Mara Biasin, Lara Gibellini, Daria Trabattoni · 2026 · Journal of Virology
VPS13C-mediated endoplasmic reticulum-lysosome tethering in neuronal stress responses
Rabab S. Hamad, Eman Hamza, Ebtehal M. Abdel-Aal, Elsayed A. Elmorsy, Hanan Eissa, Alshaimaa A. Farrag, Ahmed Shata, Ghada M. Nassar, Nesreen Elsayed Morsy, Ahmed A. El‐Mansy et al. · 2026 · Tissue and Cell
Reversible formation of S - d -3-phosphoglyceroyl glutathione contributes to cellular protection from acylation by cyclic 3-phosphoglyceric anhydride
Adilkhan Yeskendir, Adilet Bekmagambetov, Evelina Shkraba, Zariat Shatkenova, Zhanpeis Issayev, Aizhan Akhmadi, Dos D. Sarbassov, Darkhan Utepbergenov · 2026 · RSC Chemical Biology
Reduced dopaminergic reinforcement, not learning capacity, limits operant learning in aging Drosophila
Ishrat Jahan, Helen Holvoet, Jean‐François De Backer, Ilona C Grunwald Kadow · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
CSF glucosylsphingosine is a central readout of GCase impairment across genetic and sporadic Parkinson’s disease
Jillian H. Kluss, Di Jiang, Shan V. Andrews, Ritesh Ravi, Romeo D. Maciuca, Buyankhishig Tsogtbaatar, Chau Tran, Meng Fang, Eric A. Macklin, Anastasia G. Henry et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Mitochondrial Quality Control and Pathogenic Signaling Networks in Parkinson’s Disease
Xiaobing Zhang, Huiyu Li, Jiaxin Zhao, Jin Tang, X Li, Pengjing Li, Qingyun Zhao, Qi Wang, Wei Zou · 2026 · Current Issues in Molecular Biology
Tier-specific location of Lewy body pathology and related neuromelanin levels drive dopaminergic cell vulnerability in pigmented non-human primates
Julia Chocarro, Alberto J. Rico, Goiaz Ariznabarreta, Elena Lorenzo-Ramos, Mario M. Ilarduya, Cristina Canales, Adriana Leon-Villares, Javier Blesa, Jose Angel Obeso, José Luis Lanciego · 2026 · Neurobiology of Disease
Iron dyshomeostasis and enhanced myelination in the prefrontal cortex and ventral basal ganglia of a DJ-1 knockout model of early-onset Parkinson's disease
Sijie Liu, Wei Chen, X H Chen, Yue Cai, Linlin Cheng, Haodong Guo, Fuchun Lin, Yan Kang, Fang Wang, Y ZHAO et al. · 2026 · Neurobiology of Disease
Endogenous Neurotoxicity: A Pathophysiological Consequence of Homeostatic Dysfunction
Sangeeta Yanglem, Borish Loushambam, Sorokhaibam Mexico Singh, Sivakumar Vijayaraghavalu · 2026 · Neuroglia
Interaction of renalase and its peptides RP211-223 and RP224-232 with the mitochondrial fraction of rat brain: a link to neurodegeneration?
О.А. Бунеева, Valerii I. Fedchenko, S.A. Kaloshina, А. А. Калошин, V. G. Zgoda, Medvedev Ae · 2026 · Biomeditsinskaya Khimiya
The conundrum of alpha-synuclein antibody failures in Parkinson’s disease: a narrative review of mechanisms and alternative metabolic hypotheses
Anastasia M. Bougea · 2026 · Therapeutic Advances in Neurological Disorders
Crosstalk Between Parkinson's Disease and Colorectal Cancer: Genetic Mechanisms, Gut Microbiota, and Therapeutic Insights
Jiacheng Ying, Zhengyuan Fang, C L Zhang, Xu Liu, Jianzhi Cui, Zezhi Li, Jia‐Yin Tang · 2026 · Health care science
Loss of Fragile X Protein Impacts α-Synuclein Homeostasis via Insulin-Degrading Enzyme in Parkinson’s Disease
Pan Gao, Yiyang Wu, Svenja-Lotta Rumpf, Weilin CHEN, P Schaffer, Carla Kolb, Pieter Giesbertz, Xiao Feng, Léa Dias Rodrigues, Yingyang He et al. · 2026 · Research Square
Selective Neurodegeneration in Patients with Parkinson’s Disease
Furkat A. Yusupov, M. Abdykadyrov · 2026 · Neuroscience and Behavioral Physiology
Cannabidiol confers neuroprotection against 6-OHDA toxicity by rescuing Nrf2 proteostasis and preserving mitochondrial integrity
Juan C Jurado Coronel, Martin L. Duennwald · 2026 · Free Radical Biology and Medicine
Selective Neuronal Vulnerability to Alpha-Synuclein Pathology in Parkinson’s Disease: A Critical Review of Mechanistic Rationale and Biomarker Stratification
Livia Livinț Popa, Andreea Nicolaie, Alexandra Maștaleru, Ștefan Socolov, Mihaela Mitrea, Gabriela Popescu, Thomas Gabriel Schreiner, Roxana Ana Covali, Laura-Elena Cucu, Lucia Corina Dima-Cozma et al. · 2026 · Medical Sciences
Cell Death in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets
Tianjiao Li, Qian Zhang, Yichen Wu, Ruixue Huang · 2026 · MedComm
Genetic Architecture of Synaptic Failure in Dementia with Lewy Bodies: From α-Synuclein Proteoforms to GBA1-Mediated Plasticity Deficits
Anastasia M. Bougea · 2026 · Genes
Glutathione Biology in Neurodegenerative and Metabolic Diseases: Molecular Mechanisms, Pathophysiological Roles, and Therapeutic Perspectives
Grażyna Gromadzka, Magdalena Kąkol, Magdalena Klimkiewicz, Maria Bendykowska · 2026 · International Journal of Molecular Sciences
Sexual dimorphism of midbrain catecholaminergic metabolism revealed by neuromelanin-sensitive MRI
Robert Raeder, Helmet Talib Karim, Michele A. Bertocci, Yui Asaoka, Chan‐Hong Moon, Manan Arora, Luke T. Roberts, Genna M. Bebko, Haris A. Aslam, Simona Graur et al. · 2026 · Molecular Psychiatry
Nanopore-enabled time-resolved monitoring of catecholamine-related phenylalanine metabolism
Mingqian Zhang, Ziyi Li, Wenying Hao, Yakun Yi, Ke Zhou, Lei Liu, Hai‐Chen Wu · 2026 · Nature Nanotechnology
Intranasal delivery of cerium oxide nanozyme and superoxide dismutase in exosomes for Parkinson's disease therapy
Xinxin Shao, Kefei Li, Yanbo Wang, Xinai He, Boyu Xiong, Shengcai Yang, Quanshun Li · 2026 · Materials Today Bio
Beyond phenotypic markers: rethinking dopaminergic identity in iPSC-derived neurons
Duc‐Hiep Bach, Thanh Liem Nguyen · 2026 · Cell Communication and Signaling
LRRK2 G2019S mutation: Implications for autophagy, metabolism, and Parkinson’s disease pathogenesis
Javier Ojalvo-Pacheco, Nerea Domínguez Rojo, Jorge Daniel Casares-Refolio, José Manuel Bravo‐San Pedro, José Manuel Fuentes · 2026 · International review of cytology
Convergent vulnerability and divergent outcomes of the dopaminergic system in Parkinson’s and Alzheimer’s diseases
Yu-Ting Xi, Chen-xi Jia, H Q Wang, P. Liu, Peng Li, Qianqian Niu, Yaling Yin · 2026 · Ageing Research Reviews
When Pathologies Collide: The Intersection of Tau and Alpha-Synuclein in Neurodegenerative Diseases
Jenna N. Hunt, Sandhya Kortagere · 2026 · Molecular Neurobiology
Mitochondrial Quality Control Imbalance in the Heterogeneity of Parkinson’s Disease: From Selective Vulnerability to Stratified Transformation
Yongxu Chen, Chunsheng Wang · 2026 · International Journal of Molecular Sciences
Dopamine-replacing gene therapy for Parkinson’s disease: biochemical background and current clinical experience
Hiroshi Ichinose, Yo Sato, Shin-Ichi MURAMATSU · 2026 · Expert Opinion on Biological Therapy
Dopamine Metabolism as a Chemically Constrained Network: Structural Regulation, Redox Liability and Dopaminergic Vulnerability in Parkinson’s Disease
Emmanuel Ortega‐Robles, Magdalena Guerra‐Crespo, Óscar Arias-Carrión · 2026 · Medical Sciences
Mitochondrial protein import stress in Parkinson’s disease: the TOM/TIM–PINK1/Parkin–DELE1/HRI axis linking mitochondrial proteostasis to neuronal death
Bo Pang, Xin Li, Yunlong Sun, Lin Ding · 2026 · Frontiers in Cell and Developmental Biology
Human iPSC-Derived Brain Cells, Organoids, and Organoids-on-Chips: Advancing Neurological Disease Modeling to Improve Clinical Outcome
Gabriel Burdman, Marco Hanna, Adriana Yndart, Arti Vashist, Madepalli Krishnappa Lakshmana · 2026 · Cells
Parkinson's disease pathogenesis: From molecular insights to novel therapies
Muhammad Danial Che Ramli, Zakirah Zainal Abidin, Blaire Okunsai, Genevieve Simboh Anak Umbar, Tumelo Elina Mauta · 2026 · Elsevier eBooks
Plasma PINK1/Parkin ratio and ATF5 as potential biomarkers associated with dyskinesia in Parkinson's disease
Shuangjie Qian, Weiqi Xiang, Keke Chen, Yishu Du, Binbing Xu, Qi Duan, Xi Xiong, Jialong Hou, Tao Jiang, Dewei Xie et al. · 2026 · Neurobiology of Disease
Parkinson’s disease, Gaucher disease, and bistability in the lysosomal degradation pathway
Michael C. Reed, Janet Best, Peter Lansbury, Craig Justman, H. Frederik Nijhout · 2026 · Mathematical Biosciences
A longitudinal study of rotenone-induced Parkinsonism in mice
Prince Joshi, Fan Fan, Xuelin Lou · 2026 · iScience
BindingDB Entry 50009184: Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase.
BindingDB · 2021 · UC San Diego
BindingDB Entry 50016957: Medicinal Chemistry and Chemical Biology of Nurr1 Modulators: An Emerging Strategy in Neurodegeneration.
BindingDB · 2023 · UC San Diego
BindingDB Entry 50007758: Discovery of coumarin Mannich base derivatives as multifunctional agents against monoamine oxidase B and neuroinflammation for the treatment of Parkinson's disease.
BindingDB · 2021 · UC San Diego
A Novel Glucocerebrosidase Allosteric Activator Prevents MPTP-Induced Neurodegeneration in Mice
Anton Emelyanov, Alena E. Kopytova, Лавринова Анна Олеговна, Georgy N. Rychkov, Margarita Rudenok, Ivan Rybolovlev, Farid Ibatullin, Victoria N. Pidyurchina, Alexandra V. Artynyuk, Mikhail A. Nikolaev et al. · 2026 · International Journal of Molecular Sciences